Levitra: Reliable Treatment for Erectile Dysfunction
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.44 | $34.40 (0%) | 🛒 Add to cart |
| 20 | $2.36 | $68.80 $47.30 (31%) | 🛒 Add to cart |
| 30 | $2.01 | $103.20 $60.20 (42%) | 🛒 Add to cart |
| 60 | $1.43 | $206.40 $86.00 (58%) | 🛒 Add to cart |
| 90 | $1.24 | $309.60 $111.80 (64%) | 🛒 Add to cart |
| 120 | $1.15 | $412.80 $137.60 (67%) | 🛒 Add to cart |
| 180 | $1.05 | $619.20 $189.20 (69%) | 🛒 Add to cart |
| 270 | $0.96 | $928.80 $258.00 (72%) | 🛒 Add to cart |
| 360 | $0.86
Best per pill | $1238.40 $309.60 (75%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | 🛒 Add to cart |
| 20 | $2.79 | $77.40 $55.90 (28%) | 🛒 Add to cart |
| 30 | $2.44 | $116.10 $73.10 (37%) | 🛒 Add to cart |
| 60 | $2.01 | $232.20 $120.40 (48%) | 🛒 Add to cart |
| 90 | $1.91 | $348.30 $172.00 (51%) | 🛒 Add to cart |
| 120 | $1.72 | $464.40 $206.40 (56%) | 🛒 Add to cart |
| 180 | $1.58 | $696.60 $283.80 (59%) | 🛒 Add to cart |
| 270 | $1.40 | $1044.90 $378.40 (64%) | 🛒 Add to cart |
| 360 | $1.19
Best per pill | $1393.20 $430.00 (69%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Levitra (vardenafil HCl) is a prescription medication specifically formulated to treat erectile dysfunction (ED) in men. As a phosphodiesterase type 5 (PDE5) inhibitor, it works by increasing blood flow to the penis, facilitating the achievement and maintenance of an erection sufficient for sexual activity. It is clinically proven, with a rapid onset of action and efficacy that is maintained even in challenging patient subgroups, including those with diabetes or post-prostatectomy. Levitra represents a well-established option in the therapeutic arsenal for ED, offering a balance of potency, duration, and tolerability.
Features
- Active Pharmaceutical Ingredient: Vardenafil hydrochloride.
- Available Dosage Strengths: 2.5 mg, 5 mg, 10 mg, and 20 mg film-coated tablets.
- Mechanism of Action: Selective inhibition of phosphodiesterase type 5 (PDE5).
- Pharmacokinetic Profile: Median time to maximum plasma concentration (Tmax) is approximately 0.5-2.5 hours post-dosing.
- Administration: Oral administration, with or without food (high-fat meals may delay absorption).
- Excipients: Includes microcrystalline cellulose, crospovidone, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, yellow iron oxide, and red iron oxide.
Benefits
- Rapid Onset of Action: Clinical studies demonstrate that Levitra can start working in as little as 15-25 minutes in some men, allowing for greater spontaneity.
- Proven Efficacy in Diverse Patient Populations: Demonstrates significant improvement in erectile function across a broad range of patients, including those with ED associated with diabetes mellitus, hypertension, or post-radical prostatectomy.
- High Reliability: Offers a consistent and reliable response to sexual stimulation, helping to restore confidence and reduce anxiety related to sexual performance.
- Flexible Dosing Options: The range of available strengths (2.5 mg to 20 mg) allows healthcare providers to tailor the dose for optimal efficacy and tolerability for the individual patient.
- Sustained Duration: Provides a therapeutic window that typically lasts up to 4-5 hours, offering a sufficient period for successful sexual activity.
- Well-Characterized Safety Profile: Has been extensively studied in clinical trials and post-marketing surveillance, with a known and manageable side effect profile.
Common use
Levitra is indicated for the treatment of erectile dysfunction, the consistent or recurrent inability to achieve and/or maintain a penile erection sufficient for satisfactory sexual performance. It is not indicated for use by women, children, or adolescents. It is crucial to understand that Levitra is not an aphrodisiac and does not increase sexual desire. Its mechanism of action is dependent on sexual stimulation; it will not cause an erection in the absence of arousal.
Dosage and direction
The recommended starting dose for most patients is 10 mg, taken orally approximately 25-60 minutes before anticipated sexual activity. The dosage may be increased to a maximum recommended dose of 20 mg or decreased to 5 mg based on efficacy and tolerability. The dosing frequency should not exceed once per 24-hour period. For patients 65 years and older, or those with hepatic impairment (Child-Pugh B), a starting dose of 5 mg is recommended. The 2.5 mg dose is typically reserved for daily dosing regimens as prescribed by a physician. The tablet should be swallowed whole with a glass of water; it is not intended to be split, crushed, or chewed.
Precautions
- Cardiovascular Status: Patients should undergo a thorough medical history and physical examination to diagnose ED, determine potential underlying causes, and identify appropriate treatment. Sexual activity carries a potential cardiac risk. Therefore, treatments for ED, including Levitra, should not be used in men for whom sexual activity is inadvisable due to their underlying cardiovascular status.
- Priapism: Prolonged erections lasting more than 4 hours and priapism (a painful erection lasting more than 6 hours) have been reported infrequently. This condition requires immediate medical attention to prevent long-term penile tissue damage and permanent loss of potency.
- Effects on the Eye: Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely post-marketing in connection with PDE5 inhibitor use. It is not possible to determine if these events are related to the drug or other factors. Patients who have experienced NAION in one eye are at increased risk of NAION in the other eye.
- Sudden Hearing Loss: Cases of sudden decrease or loss of hearing have been reported post-marketing, sometimes accompanied by tinnitus and dizziness.
- Alpha-Blockers and Blood Pressure: Concomitant use with alpha-blockers can lead to symptomatic hypotension in some patients. See Drug Interactions.
- Renal or Hepatic Impairment: Dose adjustment is recommended for patients with significant hepatic impairment. Please refer to the full prescribing information for specific guidance.
Contraindications
- Concomitant administration of Levitra with any form of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate or dinitrate) or nitric oxide donors (e.g., amyl nitrite) in any form, at any time. This combination can cause a severe and potentially life-threatening drop in blood pressure.
- Concomitant administration with guanylate cyclase stimulators, such as riociguat.
- Known hypersensitivity to vardenafil or any of the tablet’s excipients.
- Patients with a history of serious hypersensitivity reaction to any PDE5 inhibitor.
Possible side effect
The most common side effects are generally mild to moderate and transient. They are primarily related to the drug’s vasodilatory properties.
- Very Common (≥1/10): Headache.
- Common (≥1/100 to <1/10): Flushing, dizziness, dyspepsia, nasal congestion, rhinitis, sinusitis.
- Uncommon (≥1/1,000 to <1/100): Palpitations, tachycardia, nausea, increased creatine kinase, back pain, myalgia, blurred vision, changes in color vision (cyanopsia).
- Rare (≥1/10,000 to <1/1,000): Hypersensitivity reactions (including rash, hives), syncope, priapism, NAION, sudden hearing loss.
- Frequency not known: Seizure, transient global amnesia.
Drug interaction
- Nitrates: Absolute Contraindication. Concomitant use can cause profound hypotension, syncope, stroke, or myocardial infarction.
- Alpha-Adrenergic Blocking Agents: Concomitant use can potentiate the blood-pressure-lowering effects. This combination should be approached with caution. Levitra should be initiated at the 5 mg dose only after the patient has been stabilized on alpha-blocker therapy.
- Antihypertensives: Vardenafil may add to the blood-pressure-lowering effect of other antihypertensive agents.
- Potent CYP3A4 Inhibitors: Drugs such as ketoconazole, itraconazole, indinavir, ritonavir, atazanavir, clarithromycin, and grapefruit juice can significantly increase vardenafil plasma concentrations. Dose adjustments or avoidance is required. For example, the maximum recommended dose of Levitra is 2.5 mg when taken with ketoconazole or itraconazole, and 2.5 mg when taken with indinavir or ritonavir.
- Potent CYP3A4 Inducers: Drugs such as rifampin can decrease vardenafil exposure, potentially reducing efficacy.
- Other PDE5 Inhibitors: Concomitant use with other medications for erectile dysfunction (e.g., sildenafil, tadalafil) is not recommended.
Missed dose
Levitra is taken on an as-needed basis. It is not part of a daily dosing schedule; therefore, the concept of a “missed dose” does not apply. Do not take more than one dose within a 24-hour period.
Overdose
In cases of overdose, the expected pharmacologic effects would be an exaggeration of the known dose-related side effects, primarily severe hypotension. Standard supportive measures should be employed. This includes placing the patient in the supine position with the legs elevated to help restore blood pressure and ensure adequate hydration. Hemodialysis is not expected to accelerate clearance as vardenafil is highly bound to plasma proteins and not significantly eliminated in the urine.
Storage
Store Levitra tablets at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the medication in its original blister pack or bottle to protect it from light and moisture. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
- Clinical Trial Data: A meta-analysis of randomized controlled trials published in the Journal of Sexual Medicine concluded that vardenafil significantly improved erectile function, intercourse satisfaction, and overall satisfaction across all assessed domains of the International Index of Erectile Function (IIEF) questionnaire compared to placebo. Efficacy was demonstrated in broad populations, including men with diabetes.
- Patient Feedback: In post-marketing surveys and patient-reported outcome studies, a significant majority of men report improved ability to achieve and maintain an erection, increased confidence, and improved overall sexual satisfaction. The rapid onset of action is frequently cited as a key benefit. Common feedback on side effects aligns with the clinical profile, noting headache and flushing as the most frequent but generally tolerable issues.
- Expert Opinion: Urologists and sexual medicine specialists often regard Levitra as a valuable therapeutic option due to its proven efficacy, rapid onset, and favorable profile in difficult-to-treat patient groups. It is considered a well-established and reliable agent within the PDE5 inhibitor class.